Healthcare & Life Sciences

Advalytix AG

series-c-plus
series-c-plus
Stage
1
Investors

About

Advalytix AG develops products and systems for cell-based molecular diagnostics, with a focus on single-cell molecular biology and electrophoresis technologies.

Explore Advalytix AG's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.